Company · CIK 0001404644 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Neurogene Inc. · NGNE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 SForm 4 → | Jul 7, 9:08 pm EDT | Christine Mikail CvijicPresident and CFO, Director | 4,800 | $36.12 | $173,375 | 84,040 | −5.40% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 6:42 pm EDT | Christine Mikail CvijicPresident and CFO, Director | 4,800 | $34.71 | $166,586 | 88,840 | −5.13% | 10b5-1 |
| May 14, 2018 SForm 4 → | May 16, 7:45 pm EDT | Daniel J LevittDirector | 3,906 | $12.67 | $49,489 | 0 | −100% | plan? |
| May 14, 2018 MForm 4 → | May 16, 7:45 pm EDT | Daniel J LevittDirector | 3,906 | $10.56 | $41,247 | 3,906 | — | plan? |
| Mar 15, 2018 SForm 4 → | Mar 19, 5:58 pm EDT | Lloyd MacKenzieChief Operating Officer | 1,302 | $14.63 | $19,049 | 0 | −100% | plan? |
| Mar 15, 2018 MForm 4 → | Mar 19, 5:58 pm EDT | Lloyd MacKenzieChief Operating Officer | 1,302 | $10.56 | $13,749 | 1,302 | — | plan? |
| Jun 1, 2017 SForm 4 → | Jun 5, 7:00 pm EDT | David MainPresident and CEO, Director | 15,625 | $13.26 | $207,244 | 71,530 | −17.9% | plan? |
| Jun 1, 2017 MForm 4 → | Jun 5, 7:00 pm EDT | David MainPresident and CEO, Director | 15,625 | $9.60 | $150,000 | 75,155 | — | plan? |
| Jan 9, 2017 PForm 4 → | Jan 9, 6:46 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 398,062 | $17.18 | $6,836,813 | 9,764,459 | +4.25% | plan? |
| Sep 20, 2016 PForm 4 → | Sep 21, 4:28 pm EDT | BAKER BROS. ADVISORS LP +310% Owner | 2,783,605 | $12.25 | $34,110,452 | 1,131,625 | — | plan? |
| Mar 15, 2016 PForm 4 → | Mar 16, 6:56 pm EDT | BAKER BROS. ADVISORS LP +310% Owner | 471,667 | $7.99 | $3,770,636 | 6,928,119 | +7.31% | plan? |
| Jan 22, 2016 PForm 4 → | Jan 26, 6:53 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 140,786 | $10.80 | $1,520,909 | 6,502,773 | +2.21% | plan? |
| Jan 19, 2016 PForm 4 → | Jan 20, 7:12 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 190,079 | $9.33 | $1,773,653 | 6,375,941 | +3.07% | plan? |
| Jan 14, 2016 PForm 4/A → | Jan 15, 5:37 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 202,623 | $8.28 | $1,677,083 | 6,204,630 | +3.38% | plan? |
| Jan 14, 2016 PForm 4 → | Jan 15, 5:13 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 202,623 | $8.28 | $1,677,083 | 6,204,630 | +3.38% | plan? |
| Oct 31, 2015 JForm 4 → | Nov 3, 5:56 pm EST | Gary BridgerDirector | 1,543,989 | — | — | 0 | — | plan? |
| Sep 10, 2015 PForm 4 → | Sep 11, 4:11 pm EDT | BAKER BROS. ADVISORS LP +310% Owner | 2,480,032 | $15.50 | $38,440,496 | 6,022,104 | +70.0% | plan? |
| Aug 24, 2015 PForm 4 → | Aug 26, 4:48 pm EDT | David Chilton MitchellVP Global Regulatory & Quality | 3,575 | $17.81 | $63,671 | 3,575 | — | plan? |
| Aug 12, 2015 SForm 4 → | Aug 14, 8:39 pm EDT | Lloyd MacKenzieVP Technical Operations | 35,887 | $18.67 | $670,010 | 0 | −100% | plan? |
| Aug 12, 2015 MForm 4 → | Aug 14, 8:39 pm EDT | Lloyd MacKenzieVP Technical Operations | 35,887 | $5.76 | $206,709 | 35,887 | — | plan? |
| Aug 12, 2015 SForm 4 → | Aug 14, 8:36 pm EDT | Kamran AlamCFO, Vice President Finance | 29,079 | $18.67 | $542,905 | 0 | −100% | plan? |
| Aug 12, 2015 MForm 4 → | Aug 14, 8:36 pm EDT | Kamran AlamCFO, Vice President Finance | 29,079 | $5.76 | $167,495 | 29,079 | — | plan? |
| Aug 11, 2015 PForm 4 → | Aug 13, 8:20 pm EDT | David Chilton MitchellVP Global Regulatory & Quality | 1,600 | $24.36 | $38,976 | 1,600 | — | plan? |
| Aug 10, 2015 SForm 4 → | Aug 12, 4:30 pm EDT | PFIZER INC10% Owner | 259,927 | $26.47 | $6,880,295 | 975,403 | −21.0% | plan? |
| Aug 10, 2015 SForm 4 → | Aug 12, 12:24 pm EDT | JOHNSON & JOHNSON +110% Owner | 1,514,821 | $22.41 | $33,944,876 | 100,000 | −93.8% | plan? |
| Sep 2, 2014 PForm 5 → | Feb 9, 2015, 5:30 pm EST | Stephen B ShrewsburyCMO; Senior VP Clinical Dev. | 400 | $8.22 | $3,288 | 400 | — | plan? |
| Mar 12, 2014 PForm 4/A → | Feb 3, 2015, 12:05 pm EST | JOHNSON & JOHNSON +110% Owner | 272,727 | $11.00 | $2,999,997 | 1,664,821 | +19.6% | plan? |
| Mar 12, 2014 CForm 4/A → | Feb 3, 2015, 12:05 pm EST | JOHNSON & JOHNSON +110% Owner | 1,392,094 | — | — | 1,392,094 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 AForm 4/A → | Jun 16, 2026, 5:31 pm EDT | Keith WoodsDirector | 12,050 | — | — | 12,050 | — | |
| Jun 14, 2024 AForm 4/A → | Jun 16, 2026, 5:32 pm EDT | Keith WoodsDirector | 7,700 | — | — | 7,700 | — | |
| Jan 16, 2024 AForm 4/A → | Jun 16, 2026, 5:32 pm EDT | Keith WoodsDirector | 15,400 | — | — | 15,400 | — | |
| Aug 7, 2018 AForm 4 → | Aug 9, 7:07 pm EDT | David MainPresident and CEO, Director | 415,000 | — | — | 415,000 | — | |
| Aug 7, 2018 AForm 4 → | Aug 9, 7:05 pm EDT | Shelley McCloskeyVP, HR and Administration | 75,000 | — | — | 75,000 | — | |
| Aug 7, 2018 AForm 4 → | Aug 9, 7:04 pm EDT | Lloyd MacKenzieChief Operating Officer | 145,000 | — | — | 145,000 | — | |
| Aug 7, 2018 AForm 4 → | Aug 9, 7:03 pm EDT | Kamran AlamCFO, Vice President Finance | 195,000 | — | — | 195,000 | — | |
| May 14, 2018 MForm 4 → | May 16, 7:45 pm EDT | Daniel J LevittDirector | 3,906 | — | — | 0 | — | |
| May 7, 2018 AForm 4 → | May 9, 6:19 pm EDT | Todd E SimpsonDirector | 15,000 | — | — | 15,000 | — | |
| May 7, 2018 AForm 4 → | May 9, 6:17 pm EDT | Robert PelzerDirector | 15,000 | — | — | 15,000 | — | |
| May 7, 2018 AForm 4 → | May 9, 6:15 pm EDT | Gary BridgerDirector | 15,000 | — | — | 15,000 | — | |
| May 7, 2018 AForm 4 → | May 9, 6:13 pm EDT | Sean P. NolanDirector | 15,000 | — | — | 15,000 | — | |
| May 7, 2018 AForm 4 → | May 9, 6:11 pm EDT | Daniel J LevittDirector | 15,000 | — | — | 15,000 | — | |
| May 7, 2018 AForm 4 → | May 9, 4:01 pm EDT | BAKER BROS. ADVISORS LP +5Director, 10% Owner | 30,000 | — | — | 30,000 | — | |
| Mar 15, 2018 MForm 4 → | Mar 19, 5:58 pm EDT | Lloyd MacKenzieChief Operating Officer | 1,302 | — | — | 0 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 5:04 pm EDT | Barbara TroupinChief Medical Officer | 75,000 | — | — | 75,000 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 4:58 pm EDT | Shelley McCloskeyVP, HR and Administration | 45,000 | — | — | 45,000 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 4:56 pm EDT | David MainPresident and CEO, Director | 225,000 | — | — | 225,000 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 4:54 pm EDT | Lloyd MacKenzieChief Operating Officer | 75,000 | — | — | 75,000 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 4:53 pm EDT | Abigail JenkinsChief Commercial Officer | 75,000 | — | — | 75,000 | — | |
| Mar 9, 2018 AForm 4 → | Mar 13, 4:51 pm EDT | Kamran AlamCFO, Vice President Finance | 75,000 | — | — | 75,000 | — | |
| Jun 1, 2017 MForm 4 → | Jun 5, 7:00 pm EDT | David MainPresident and CEO, Director | 15,625 | — | — | 0 | — | |
| May 8, 2017 AForm 4 → | May 10, 6:52 pm EDT | Todd E SimpsonDirector | 9,000 | — | — | 9,000 | — | |
| May 8, 2017 AForm 4 → | May 10, 6:47 pm EDT | Sean P. NolanDirector | 9,000 | — | — | 9,000 | — | |
| May 8, 2017 AForm 4 → | May 10, 6:36 pm EDT | Robert PelzerDirector | 9,000 | — | — | 9,000 | — | |
| May 8, 2017 AForm 4 → | May 10, 6:33 pm EDT | Daniel J LevittDirector | 9,000 | — | — | 9,000 | — | |
| May 8, 2017 AForm 4 → | May 10, 6:29 pm EDT | Gary BridgerDirector | 9,000 | — | — | 9,000 | — | |
| May 8, 2017 AForm 4 → | May 9, 4:44 pm EDT | BAKER BROS. ADVISORS LP +5Director, 10% Owner | 36,000 | — | — | 36,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 9:22 pm EST | Barbara TroupinChief Medical Officer | 40,000 | — | — | 40,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 9:20 pm EST | David Chilton MitchellVP Global Regulatory & Quality | 25,000 | — | — | 25,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 9:18 pm EST | Shelley McCloskeyVP, HR and Administration | 30,000 | — | — | 30,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 9:16 pm EST | David MainPresident and CEO, Director | 185,000 | — | — | 185,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 9:13 pm EST | Lloyd MacKenzieVP Technical Operations | 50,000 | — | — | 50,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 9:10 pm EST | Abigail JenkinsChief Commercial Officer | 80,000 | — | — | 80,000 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 9:08 pm EST | Kamran AlamCFO, Vice President Finance | 80,000 | — | — | 80,000 | — | |
| Nov 8, 2016 AForm 4 → | Nov 10, 5:38 pm EST | Barbara TroupinChief Medical Officer | 50,000 | — | — | 50,000 | — | |
| Aug 3, 2016 AForm 4 → | Aug 5, 6:23 pm EDT | Abigail JenkinsChief Commercial Officer | 50,000 | — | — | 50,000 | — | |
| May 9, 2016 AForm 4 → | May 11, 6:18 pm EDT | Sean P. NolanDirector | 7,500 | — | — | 7,500 | — | |
| May 9, 2016 AForm 4 → | May 11, 5:44 pm EDT | Robert PelzerDirector | 7,500 | — | — | 7,500 | — | |
| May 9, 2016 AForm 4 → | May 11, 5:43 pm EDT | Todd E SimpsonDirector | 7,500 | — | — | 7,500 | — | |
| May 9, 2016 AForm 4 → | May 11, 5:37 pm EDT | Daniel J LevittDirector | 7,500 | — | — | 7,500 | — | |
| May 9, 2016 AForm 4 → | May 11, 5:35 pm EDT | Gary BridgerDirector | 7,500 | — | — | 7,500 | — | |
| Mar 10, 2016 AForm 4 → | Mar 14, 5:42 pm EDT | Stephen B ShrewsburyCMO; Senior VP Clinical Dev. | 35,000 | — | — | 35,000 | — | |
| Mar 10, 2016 AForm 4 → | Mar 14, 5:40 pm EDT | David Chilton MitchellVP Global Regulatory & Quality | 25,000 | — | — | 25,000 | — | |
| Mar 10, 2016 AForm 4 → | Mar 14, 5:38 pm EDT | David MainPresident and CEO, Director | 120,000 | — | — | 120,000 | — | |
| Mar 10, 2016 AForm 4 → | Mar 14, 5:36 pm EDT | Lloyd MacKenzieVP Technical Operations | 35,000 | — | — | 35,000 | — | |
| Mar 10, 2016 AForm 4 → | Mar 14, 5:34 pm EDT | Kamran AlamCFO, Vice President Finance | 40,000 | — | — | 40,000 | — | |
| Jan 10, 2016 AForm 5 → | Feb 14, 2017, 5:37 pm EST | Shelley McCloskeyVP, HR and Administration | 35,000 | — | — | 35,000 | — | |
| Aug 12, 2015 MForm 4 → | Aug 14, 8:39 pm EDT | Lloyd MacKenzieVP Technical Operations | 35,887 | — | — | 1,872 | — | |
| Aug 12, 2015 MForm 4 → | Aug 14, 8:36 pm EDT | Kamran AlamCFO, Vice President Finance | 29,079 | — | — | 0 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:39 pm EDT | Todd E SimpsonDirector | 5,000 | — | — | 5,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:38 pm EDT | Stephen B ShrewsburyCMO; Senior VP Clinical Dev. | 25,000 | — | — | 25,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:29 pm EDT | Robert PelzerDirector | 5,000 | — | — | 5,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:27 pm EDT | Sean P. NolanDirector | 10,000 | — | — | 10,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:18 pm EDT | David MainPresident and CEO, Director | 65,000 | — | — | 65,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:07 pm EDT | Lloyd MacKenzieVP Technical Operations | 25,000 | — | — | 25,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:01 pm EDT | Daniel J LevittDirector | 5,000 | — | — | 5,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 4:57 pm EDT | Gary BridgerDirector | 5,000 | — | — | 5,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 4:54 pm EDT | Kamran AlamCFO, Vice President Finance | 25,000 | — | — | 25,000 | — | |
| Jan 11, 2015 AForm 4 → | Jan 13, 5:10 pm EST | David Chilton MitchellVP Global Regulatory & Quality | 35,000 | — | — | 35,000 | — | |
| Mar 12, 2014 CForm 4/A → | Feb 3, 2015, 12:05 pm EST | JOHNSON & JOHNSON +110% Owner | 1,392,094 | — | — | 0 | — |